Detalhe da pesquisa
1.
Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability.
BMC Biotechnol
; 12: 77, 2012 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23110350
2.
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.
NPJ Vaccines
; 6(1): 144, 2021 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857771
3.
Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line.
PLoS One
; 12(4): e0175633, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423032
4.
Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.
Ther Adv Vaccines
; 3(4): 97-108, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26478817
5.
Randomized comparison of the safety of Flublok(®) versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥ 50 years of age.
Vaccine
; 33(48): 6622-8, 2015 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26529070
6.
Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopes.
Vaccine
; 27(50): 7087-95, 2009 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19786132
7.
A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice.
Vaccine
; 24(17): 3624-31, 2006 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-16497416
8.
Safety testing and use of insect cells for recombinant protein production.
PDA J Pharm Sci Technol
; 64(5): 396-418, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21502044
9.
Myosin-IXb is a single-headed and processive motor.
J Biol Chem
; 277(14): 11679-83, 2002 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-11801597